Hunan Jiudian Pharmaceutical Dividends and Buybacks
Dividend criteria checks 3/6
Hunan Jiudian Pharmaceutical is a dividend paying company with a current yield of 0.93% that is well covered by earnings.
Key information
0.9%
Dividend yield
-0.2%
Buyback Yield
Total Shareholder Yield | 0.8% |
Future Dividend Yield | 1.8% |
Dividend Growth | 23.9% |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | CN¥0.229 |
Payout ratio | 22% |
Recent dividend and buyback updates
Recent updates
Do Hunan Jiudian Pharmaceutical's (SZSE:300705) Earnings Warrant Your Attention?
Oct 22With Hunan Jiudian Pharmaceutical Co., Ltd. (SZSE:300705) It Looks Like You'll Get What You Pay For
Aug 12Here's Why Hunan Jiudian Pharmaceutical (SZSE:300705) Can Manage Its Debt Responsibly
Jun 23Hunan Jiudian Pharmaceutical (SZSE:300705) Is Increasing Its Dividend To CN¥0.321
May 21Here's Why We Think Hunan Jiudian Pharmaceutical (SZSE:300705) Might Deserve Your Attention Today
Apr 12Earnings Not Telling The Story For Hunan Jiudian Pharmaceutical Co., Ltd. (SZSE:300705) After Shares Rise 27%
Mar 04Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 300705 has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: 300705's dividend payments have increased, but the company has only paid a dividend for 7 years.
Dividend Yield vs Market
Hunan Jiudian Pharmaceutical Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (300705) | 0.9% |
Market Bottom 25% (CN) | 0.6% |
Market Top 25% (CN) | 2.2% |
Industry Average (Pharmaceuticals) | 1.7% |
Analyst forecast (300705) (up to 3 years) | 1.8% |
Notable Dividend: 300705's dividend (0.93%) is higher than the bottom 25% of dividend payers in the CN market (0.55%).
High Dividend: 300705's dividend (0.93%) is low compared to the top 25% of dividend payers in the CN market (2.16%).
Earnings Payout to Shareholders
Earnings Coverage: With its low payout ratio (21.7%), 300705's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonably low cash payout ratio (48.3%), 300705's dividend payments are well covered by cash flows.